Sterol-activated amyloid beta fibril formation
Journal of Biological Chemistry · 2023
DOI: 10.1016/j.jbc.2023.105445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Ian Cook und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The metabolic processes that link Alzheimer's disease (AD) to elevated cholesterol levels in the brain are not fully defined. Amyloid beta (Aβ) plaque accumulation is believed to begin decades prior to symptoms and to contribute significantly to the disease. Cholesterol and its metabolites accelerate plaque formation through as-yet-undefined mechanisms. Here, the mechanism of cholesterol (CH) and cholesterol 3-sulfate (CS) induced acceleration of Aβ42 fibril formation is examined in quantitative ligand binding, Aβ42 fibril polymerization, and molecular dynamics studies. Equilibrium and pre-steady-state binding studies reveal that monomeric Aβ42•ligand complexes form and dissociate rapidly relative to oligomerization, that the ligand/peptide stoichiometry is 1-to-1, and that the peptide is likely saturated in vivo. Analysis of Aβ42 polymerization progress curves demonstrates that ligands accelerate polymer synthesis by catalyzing the conversion of peptide monomers into dimers that nucleate the polymerization reaction. Nucleation is accelerated ∼49-fold by CH, and ∼13,000-fold by CS - a minor CH metabolite. Polymerization kinetic models predict that at presumed disease-relevant CS and CH concentrations, approximately half of the polymerization nuclei will contain CS, small oligomers of neurotoxic dimensions (∼12-mers) will contain substantial CS, and fibril-formation lag times will decrease 13-fold relative to unliganded Aβ42. Molecular dynamics models, which quantitatively predict all experimental findings, indicate that the acceleration mechanism is rooted in ligand-induced stabilization of the peptide in non-helical conformations that readily form polymerization nuclei.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: tom.leyh@einstein.yu.edu.
Förderung
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Cook, I., & Leyh, T. S. (2023). Sterol-activated amyloid beta fibril formation. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105445
Vancouver
Cook I, Leyh TS. Sterol-activated amyloid beta fibril formation. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105445
BibTeX
@article{Cook2023,
author = {Cook, Ian and Leyh, Thomas S},
title = {Sterol-activated amyloid beta fibril formation},
journal = {Journal of Biological Chemistry},
year = {2023},
doi = {10.1016/j.jbc.2023.105445}
}
EUVIMED